GreenTree to Hold Annual General Meeting on December 22, 2020

PR Newswire

SHANGHAI, Nov. 12, 2020 /PRNewswire/ — GreenTree Hospitality Group Ltd. (NYSE: GHG), a leading hospitality management group in China (“GreenTree” or the “Company”), today announced that it will hold its annual general meeting of shareholders at 2451 Hongqiao Road, Changning District, Shanghai 200335, People’s Republic of China on December 22, 2020 at 9:00 PM U.S. Eastern Time (10:00 AM Beijing/Hong Kong Time on December 23, 2020) for the following purpose:

To approve the re-appointment of Ernst & Young Hua Ming LLP as independent auditor of the Company[1] for the fiscal year ending December 31, 2020.

Holders of record of ordinary shares of the Company at the close of business on November 22, 2020 are entitled to notice and vote at the annual general meeting or any adjournment or postponement thereof. Holders of the Company’s American depositary shares (“ADSs”) who wish to exercise their voting rights for the underlying Class A ordinary shares must act through the depositary of the Company’s ADS program, Deutsche Bank Trust Company Americas.

The notice of the annual general meeting, which sets forth the resolutions to be submitted to shareholder approval at the annual general meeting, is available on the Investor Relations section of the Company’s website at http://ir.998.com. Shareholders may obtain a copy of the Company’s 2019 annual report, free of charge, from the Investor Relations section of the Company’s website at http://ir.998.com, or by contacting GreenTree Hospitality Group Ltd. at 2451 Hongqiao Road, Changning District, Shanghai 200335, People’s Republic of China, attention: Ms. Selina Yang or Mr. Nicky Zheng, telephone: +86-21-3617-4886 ext. 7015 or ext. 6708, email: [email protected].

About GreenTree Hospitality Group Ltd.

GreenTree Hospitality Group Ltd. (“GreenTree” or the “Company”) (NYSE: GHG) is a leading hospitality management group in China. As of June 30, 2020, GreenTree had a total number of 4,066 hotels. In 2019, HOTELS magazine ranked GreenTree Top 12 Ranking among 325 largest global hotel groups in terms of number of hotels in its annual HOTELS’ 325. GreenTree was also the fourth largest hospitality company in China in 2019 based on the statistics issued by the China Hospitality Association.

GreenTree has built a strong suite of brands, including its flagship “GreenTree Inns” brand as a result of its long-standing dedication to the hospitality industry in China and consistent quality of its services, signature hotel designs, broad geographic coverage and convenient locations. GreenTree has further expanded its brand portfolio into mid-to-up-scale and luxury segments through a series of strategic investments. By offering diverse brands, through its strong membership base, expansive booking network, superior system management with reasonable charges, and fully supported by its operating departments including Decoration, Engineering, Purchasing, Operation, IT and Finance, GreenTree aims to keep closer relationships with all of its clients and partners by providing a brand portfolio that features comfort, style and value.

For more information on GreenTree, please visit http://ir.998.com.

Safe Harbor Statement

This press release contains forward-looking statements made under the “safe harbor” provisions of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. In some cases, these forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” “confident,” “future,” or other similar expressions. GreenTree may also make written or oral forward-looking statements in its reports filed with or furnished to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Any statements that are not historical facts, including statements about or based on GreenTree’s current beliefs, expectations, assumptions, estimates and projections about us and our industry, are forward-looking statements that involve known and unknown factors, risks and uncertainties that may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. Such factors and risks include, but not limited to the following: GreenTree’s goals and growth strategies; its future business development, financial condition and results of operations; trends in the hospitality industry in China and globally; competition in our industry; fluctuations in general economic and business conditions in China and other regions where we operate; the regulatory environment in which we and our franchisees operate; and assumptions underlying or related to any of the foregoing. You should not place undue reliance on these forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. All information provided, including the forward-looking statements made, in this press release are current as of the date of the press release. Except as required by law, GreenTree undertakes no obligation to update any such information or forward-looking statements to reflect events or circumstances after the date on which the information is provided or statements are made, or to reflect the occurrence of unanticipated events.


[1] This defined term “Independent Auditor” is not used elsewhere.

For more information, please contact:

Ms. Selina Yang
Phone: +86-21-3617-4886 ext. 7015
E-mail: [email protected]

Mr. Nicky Zheng
Phone: +86-21-3617-4886 ext. 6708
E-mail: [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/greentree-to-hold-annual-general-meeting-on-december-22-2020-301171790.html

SOURCE GreenTree Hospitality Group Ltd.

/R E P E A T — KORE Mining Drills 31.3 Meters of 3.2 g/t Gold Including 14.3 Meters of 6.4 g/t Gold in Large 215 Meter Step-Out at FG Gold Project/

PR Newswire

Investor Webinar Thursday November 12 at 8:30AM EST

VANCOUVER, BC, Nov. 11, 2020 /PRNewswire/ – KORE Mining Ltd. (TSXV: KORE) (OTCQX: KOREF) (“KORE” or the “Company“) announces that drill hole FG-20-377 intercepted 31.3 meters of 3.2 g/t gold, including 14.3 meters of 6.4 g/t gold, starting at 369 meters downhole in the Lower Zone of the FG Gold Project (“Project” or “FG Gold“) in the Cariboo Region of British Columbia.  This news release reports assays from drill hole FG-20-377, part of the 15-hole, 5,746 meter summer drill program at FG Gold with assays from 14 additional holes pending. 

Highlights

  • Extends Lower Zone discovery 215 meters down-dip with:
    • 31.3 meters of 3.2 g/t gold at 369 meters downhole including:
      • 14.3 meters of 6.4 g/t gold at 386 meters downhole including
      • 1.0 meters of 61.2 g/t gold at 387 meters downhole
      • 5.8 meters of 4.2 g/t gold at 394 meters downhole
  • Opens underground potential for FG Gold with 3.6 kilometers of mineralized strike
  • Assays pending for 14 additional holes over 1,780 meters of lateral strike length
    • 10 of 14 holes intersect the newly discovered Lower Zone
    • 7 of 14 holes intersect quartz veins containing visible gold
  • Remains underexplored along a 20-kilometer trend, providing many opportunities for resource expansion and new discoveries on-strike and downdip

KORE CEO Scott Trebilcock comments, “The large downdip step-out announced today in FG Gold’s Lower Zone, 31.3 meters of 3.2 g/t gold including 14.3 meters of 6.4 g/t gold, demonstrates FG Gold’s underground potential.  The step-out extends the Lower Zone discovery to 300 meters downdip from the historic drilling.  With 3.6 kilometers of shallow mineralized strike, all open at depth, this underground discovery could have a profound impact of the size and grade of the deposit.  KORE has ten more holes intersecting this newly discovered Lower Zone with assays pending in the weeks ahead.”

Investor Webinar

KORE is hosting an investor webinar to discuss the results on Thursday, November 12, 2020 at 8:30AM Eastern Time (5:30AM Pacific Time).  Click HERE to register for the webinar.

The cross-section in Figure 1 show the 215 meters step-out from the June 10, 2020 Lower Zone discovery intercept of 3.9 g/t over 10 meters at 237 meters, bringing the total downdip extent of the Lower Zone to 300 meters. Assays are pending for 14 holes in which 10 intersected the newly discovered Lower Zone, as shown in the long section in Figure 2. The other four holes in the program were drilled below historic drilling along strike from the main zone, bringing the strike length tested by Kore to date since the beginning of 2020 to ~1,800 meters.  All hole locations are shown in Figure 3 in plan map.  Drilling continues with 2,000 additional meters planned at FG Gold and Gold Creek through mid-December.

The district scale of the FG Gold project is shown in Figure 4.  The 20-kilometer district trend traces the mineralized stratigraphy around the regional syncline.  Shallow historic drilling averaged only 93 meters deep, leaving the mineralization open at depth and along almost the entire trend.  Figure 5 is a regional cross-section that shows the host rock potential at depth and connection to a potential porphyritic intrusion.

Exploration Program Details

Fifteen large diameter (HQ) oriented core drill holes for a total of 5,746 meters were completed from June to October 2020 as described in the news release disseminated October 22nd, 2020.  The drill program was designed to step-out up to 200 meters downdip and continue nearly 2 kilometer along strike. The program is targeting the continuation of known gold-mineralized [orogenic] quartz veins further down-dip and along strike within prospective and un-tested regions of the targeted [phyllite] host rock. 

Assays from hole FG-20-377 are reported in this release with all other hole assays pending.  A plan map of the drill collars and traces is included in Figure 3 including the location of the cross section, Figure 1, and a long section, Figure 2

The full table of results are included below. Detailed core logs and photos are available on KORE’s website.

Due to coarse visible gold, metallic screening assays provide a much more representative sample versus conventional fire assays.  Historical drilling and assays had limited and sporadic metallic screen analyses which may have underestimated historical gold grades.  See below for more details on metallic screens.

Detailed Discussion of Results

Structural analysis and re-interpretation of historical drilling carried out prior to initiation of 2020 drilling by KORE highlighted significant potential for expanding high grade gold zones below the extents of historic drilling.  2020 drilling was designed to test the hypothesis that high grade gold zones correlating to plunge lines within both limb and hinge zones, and are extendable both at depth and along strike.  Gold-bearing quartz vein swarms appear to be correlated with high-deformation areas and hinge/limb areas of locally folded strata. The orientation [azimuth] of the drilling was intended to delineate potential continuous ‘mineral-shoots’ within the mineralized zones. 

A continuation of the shallowly drilled upper zone is intersected in hole FG-20-377 with 0.71g/t gold from 130.36 to 143.17 meters. This intersection is ~150 meters down-dip from the nearest intersection. The Lower Zone, discovered in hole FG-20-369, appears to be a corridor of quartz-vein hosted gold mineralization below and sub-parallel to the upper zone. While it does appear to extend to surface, at this stage, grade appears to increase with depth. Summer-Fall program drill holes FG-20-376 to FG-20-386 are drilled across four complete cross sections over a strike of ~650 meters designed to cross both upper and lower zones to allow for correlation both down-dip and along strike of both the upper and lower zones. Holes FG-20-387 to FG-20-390 test for lateral and down-dip mineralization in areas below sparse historic drilling. KORE drilling in 2020 tests over 1780 meters of strike length below the limits of historic drilling.

To date, the results from the 2020 drilling program are very encouraging to KORE. Early results indicate that the Company is finding further, high grade mineralized zones well outside of historic drilling, providing greater confidence in the structural interpretation and geologic model of the FG gold deposit.

Detailed Drill Hole Assays Tables for KORE Holes on Figure 1

Hole FG-20-369 (previously reported)

From
(meters)

To

(meters)

Width*
(meters)

Gold (g/t)

 

Zone


Intercept


29.0


240.0


211.0


0.9

Upper and
Lower


  including


22.0


54.0


32.0


3.0

Upper


  including


29.0


51.5


22.5


4.0


  including


29.0


30.0


1.0


42.5

  including

102.5

118.0

15.5

0.7

Upper

  including

192.5

213.5

21.0

0.9

Lower


And


237.0


247.0


10.0


3.9

Lower


  and including


239.0


240.0


1.0


33.9

Hole FG-20-371 (previously reported)

From
(meters)

To

(meters)

Width*
(meters)

Gold (g/t)

Zone

Intercept

91.0

116.0

25.0

0.6

Upper

Hole FG-20-377

From
(meters)

To

(meters)

Width
(meters)

Gold (g/t)

Zone


Intercept*


130.36


143.17


12.81


0.71

Upper


Intercept**


369


400.35


31.35


3.22

Lower


      Including


386


400.35


14.35


6.44

Lower


  Including


387


388


1.0


61.2

Lower


Including


394


399.75


5.75


4.16

Lower

* KORE has not been able to determine true width yet due to complexity of the vein structures within the mineralized zones.  KORE’s current drill program is designed to better understand the geometry and how the mineralized zones are related.  The orientation of individual quartz veins within the mineralized zones are quite variable.  Reported widths are drill indicated core length and not true width, for the reasons above.  Average grades are calculated with un-capped gold assays, as insufficient drilling has been completed to determine capping levels for higher grade gold intercepts

** Drilling data on the Lower Zone is currently limited and the true thickness and orientation of the zone is not firmly known. However, based on current data, it is estimated that FG-20-377 intercept represents ~65%-75% of the true thickness of the zone

Hole FG-20-376

Assays are pending on hole FG-20-376 however, zones of increased vein density occur where predicted. It is anticipated that these zones correlate to the nearby mineralized zones from both holes FG-20-369 and FG-20-377. Visible gold is observed at 238.75 meters in one of these vein corridors.

Hole location data is included at the end of this release.

Details of Metallic Screen Assaying

Metallic screen assays are often used in exploration when coarse or visible gold is present in the core as is the case at the FG Gold Project.  Traditionally, fire assays are undertaken on 30-50 grams of pulverised sample. The metallic screen fire assay uses a larger sample (1 kilogram in KORE’s case), with screening (to -106 micron) to separate coarse gold particles from fine material.  After screening, two samples of the fine fraction are analysed using the traditional fire assay method.  The fine fraction is expected to be reasonably homogenous.  The entire coarse fraction is assayed to determine the contribution of the coarse gold.  This method helps reduce the erratic assay results often seen in the higher-grade zones found in “nuggety” gold deposits such as the FG Gold Project.  All assays are performed at accredited independent commercial assay labs. 

Regional Geology

The FG Gold property straddles the boundary between the Omineca and Intermontane tectonics belts of the Canadian Cordillera. The eastward emplacement of the Intermontane Belt onto the Omineca Belt along the Eureka Thrust Fault caused widespread regional metamorphism and structural deformation of both Belts. The regional scale, northwest trending, shallowly plunging, Eureka Syncline is the dominant resulting structure in the project area. Rocks in the core of the Eureka Syncline are comprised of basalt, augite porphyry flows, tuffs and volcanic breccias metamorphosed to a low grade; they are structurally emplaced onto metavolcanic and sedimentary rocks of the Quesnel Terrane. The Quesnel Terrane is recognized for its prevalence of copper, gold and molybdenum mines and showings such as those at Highland Valley, Boss Mountain, QR and Mount Polley.

Property Geology

The FG Gold property is centrally located over the Eureka Syncline, strategically encompassing two limbs and the hinge zone of a gold-bearing meta-sedimentary rock unit of the Quesnel Terrane. The gold-bearing rock, a ‘knotted’ phyllite, is the host rock for gold mineralization over the 3 kilometers strike length of the Resource Area (see Figure 4). Surface mapping and geophysical inversion of airborne electromagnetic (EM) data suggests the knotted phyllite has a strike length of over 20 kilometers with potentially thickened regions occurring in the Eureka Syncline hinge zone (Kusk Zone Target) (see Figure 4).

Gold mineralization occurs in and is associated with development of quartz – Fe carbonate – muscovite – pyrite vein stockwork. The stockwork is best developed in the knotted phyllite unit. Stockwork zones locally concentrate in zones greater than 10 meters wide and are dominantly stratabound. Fe-carbonate alteration and carbonate porphyroblasts development within the knotted phyllite unit is observed to extend well outside immediate areas of veining.

About the FG Gold Project

The FG Gold project consists of 35 claims, totaling 13,008 hectares, in the eastern Cariboo region of central British Columbia, approximately 100 kilometers east of Williams Lake. The project is at low elevation and accessible by forestry roads.  FG Gold hosts an orogenic gold deposit on the northeast limb of the Eureka syncline.  The southwest limb and hinge zone are underexplored.  The Project also hosts copper-gold porphyry mineralization at the Nova Zone, discovered by KORE in 2018.  Figure 4 highlights the 20 kilometers trend of host rock expression at surface.

The 20 kilometer trend is defined by gold in soils and geophysics that traces the mineralized rock group around the regional syncline.  The Project has only been shallowly drilled where the mineralized rock group comes to surface. Past drilling averages only 93 meters deep into a steeply plunging sedimentary host rock.  Mineralization is open at depth and along almost the entire trend.  Figure 5 is a regional cross-section that shows the host rock potential at depth and potential connection to the Project’s porphyritic intrusion.

FG Gold is part of KORE’s 1,000 square kilometer South Cariboo Gold District which hosts 110 kilometers of the Eureka thrust structural trend (“Trend“) that drives gold mineralization in the District.  The Trend is highly prospective for orogenic gold deposits, some of largest in the world, and includes KORE’s Gold Creek Project.  The Cariboo region is accessible with local power, well developed road network and skilled local labour from multiple current and past operating mines.

The previous drilling targeted stratigraphic controls on mineralization and did not penetrate into the bulk of the host-rock structure. Drilling was largely done with reverse circulation (“RC”) drilling and narrow core to generate shallow bulk-disseminated gold intercept models.  Within the current resource there appears to be mineralized corridors or chutes that are open at depth in the host rock. 

The current resource at the FG Gold project is as follows:


Classification


Size (tonnes)


Grade (g/t)


Au (oz)


Au Cutoff (g/t)

Measured

5,600,000

0.812

145,000

0.50

Indicated

9,570,000

0.755

231,000

0.50

Inferred

27,493,000

0.718

634,900

0.50

More information on the FG Gold Project and resource is available in the “NI 43-101 Technical Report, Frasergold Exploration Project, Cariboo Mining Division, BC” dated July 20, 2015 by K.V. Campbell of ERSi Earth Resource Surveys Inc. and G.H. Giroux of Giroux Consultants Ltd. technical report filed under Kore’s Profile on SEDAR at www.sedar.com and on KORE’s website at www.koremining.com.

About KORE

KORE is 100% owner of a portfolio of advanced gold exploration and development assets in California and British Columbia.  KORE is supported by strategic investors Eric Sprott; and insiders, together with the management and Board, own approximately 64% of the basic shares outstanding. 

On behalf of KORE Mining Ltd

“Scott Trebilcock”
Chief Executive Officer
(888) 407-5450

QA/QC and Qualified Person

Once the drill core was received from the drill site, individual samples were determined, logged for geological attributes, sawn in half, labelled, and bagged for assay submittal. The remaining drill core was then stored at a secure site in Horsefly, BC. The Company inserted quality control samples at regular intervals within the sample stream which included blanks, preparation duplicates, and standard reference materials with all sample shipments intended to monitor laboratory performance. Sample shipment was conducted under a chain of custody procedure.

Drill core samples were submitted to Bureau Veritas’ analytical facility in Vancouver, British Columbia for preparation and analysis. Sample preparation included drying and weighing the samples, crushing the entire sample, and pulverizing 250 grams. Analysis for gold was by method FA450: 50g fire assay fusion with atomic absorption (AAS) finish with a lower limit of 0.005 ppm and upper limit of 10 ppm. Gold assays greater than 10ppm are automatically analysed by method FA550: 50g fire assay fusion with a gravimetric fusion. Metallic screen techniques were employed to assay gold mineralized zones thought to contain coarse gold. Approximately 1000 grams of coarse reject material are pulverized and screened. Two splits of the fine fraction are assayed, as well as all material that does not pass through the screen (the coarse fraction). The final gold assay reported is a weighted average of the coarse and fine fractions.

Bureau Veritas is accredited to the ISO/IEC 17025 standard for gold assays, and all analytical methods include quality control materials at set frequencies with established data acceptance criteria. Parameters for Bureau Veritas’ internal and Kore’s external blind quality control samples were acceptable for the analyses returned.

Technical information with respect to the Project contained in this news release has been reviewed and approved by Michael J. Tucker, P.Geo, who is KORE’s VP Exploration and is a qualified person under National Instrument 43-101 responsible for the technical matters of this news release.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Cautionary Statement Regarding Forward-Looking Information


This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of the Company are forward-looking statements.  Such
forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business. Management believes that these assumptions are reasonable. Forward looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. 

Such factors include, among others: risks related to exploration and development activities at the Company’s projects, and factors relating to whether or not mineralization extraction will be commercially viable;
risks related to mining operations and the hazards and risks normally encountered in the exploration, development and production of minerals, such as unusual and unexpected geological formations, rock falls, seismic activity, flooding and other conditions involved in the extraction and removal of materials; uncertainties regarding regulatory matters, including obtaining permits and complying with laws and regulations governing exploration, development, production, taxes, labour standards, occupational health, waste disposal, toxic substances, land use, environmental protection, site safety and other matters, and the potential for existing laws and regulations to be amended or more stringently implemented by the relevant authorities; uncertainties regarding estimating mineral resources, which estimates may require revision (either up or down) based on actual production experience; risks relating to fluctuating metals prices and the ability to operate the Company’s projects at a profit in the event of declining metals prices and the need to reassess feasibility of a particular project that estimated resources will be recovered or that they will be recovered at the rates estimated; risks related to title to the Company’s properties, including the risk that the Company’s title may be challenged or impugned by third parties; the ability of the Company to access necessary resources, including mining equipment and crews, on a timely basis and at reasonable cost; competition within the mining industry for the discovery and acquisition of properties from other mining companies, many of which have greater financial, technical and other resources than the Company, for, among other things, the acquisition of mineral claims, leases and other mineral interests as well as for the recruitment and retention of qualified employees and other personnel; access to suitable infrastructure, such as roads, energy and water supplies in the vicinity of the Company’s properties; and risks related to the stage of the Company’s development, including
risks relating to limited financial resources, limited availability of additional financing and potential dilution to existing shareholders; reliance on its management and key personnel; inability to obtain adequate or any insurance;  exposure to litigation or similar claims; currently unprofitable operations; risks regarding the ability of the Company and its management to manage growth; and potential conflicts of interest. 

In addition to the above summary, additional risks and uncertainties are described in the “Risks” section of the Company’s management discussion and analysis for the year ended December 31, 2019 prepared as of April 27, 2020 available under the Company’s issuer profile on www.sedar.com.

Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results, except as may be required by applicable securities laws. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. 

There is no certainty that all or any part of the mineral resource will be converted into mineral reserve. It is uncertain if further exploration will allow improving the classification of the Indicated or Inferred mineral resource.  Mineral resources are not mineral reserves and do not have demonstrated economic viability.


Cautionary Note Regarding Mineral Resource Estimates: 

Information regarding mineral resource estimates has been prepared in accordance with the requirements of Canadian securities laws, which differ from the requirements of United States Securities and Exchange Commission (“SEC”) Industry Guide 7. In October 2018, the SEC approved final rules requiring comprehensive and detailed disclosure requirements for issuers with material mining operations. The provisions in Industry Guide 7 and Item 102 of Regulation S-K, have been replaced with a new subpart 1300 of Regulation S-K under the United States Securities Act and will become mandatory for SEC registrants after January 1, 2021. The changes adopted are intended to align the SEC’s disclosure requirements more closely with global standards as embodied by the Committee for Mineral Reserves International Reporting Standards (CRIRSCO), including Canada’s NI 43-101 and CIM Definition Standards. Under the new SEC rules, SEC registrants will be permitted to disclose “mineral resources” even though they reflect a lower level of certainty than mineral reserves. Additionally, under the New Rules, mineral resources must be classified as “measured”, “indicated”, or “inferred”, terms which are defined in and required to be disclosed by NI 43-101 for Canadian issuers and are not recognized under SEC Industry Guide 7.  An “Inferred Mineral Resource” has a lower level of confidence than that applying to an “Indicated Mineral Resource” and must not be converted to a Mineral Reserve. It is reasonably expected that the majority of “Inferred Mineral Resources” could be upgraded to “Indicated Mineral Resources” with continued exploration. Accordingly, the mineral resource estimates and related information may not be comparable to similar information made public by United States companies subject to the reporting and disclosure requirements under the United States federal laws and the rules and regulations thereunder, including SEC Industry Guide 7.


Drill Hole Locations

Location, azimuth, dip and lengths for drill holes in this news release are listed in the following table:

HoleID

East

North

Elevation

Length

Azimuth

Dip

FG-20-369

665196

5797758

1525

250

231

-55

FG-20-371

665189

5797779

1525

181

228

-68

FG-20-376

665102

5797706

1567

361.5

225

-75

FG-20-377

665102

5797706

1567

439.5

225

-55

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/r-e-p-e-a-t—-kore-mining-drills-31-3-meters-of-3-2-gt-gold-including-14-3-meters-of-6-4-gt-gold-in-large-215-meter-step-out-at-fg-gold-project-301171571.html

SOURCE Kore Mining

Palatin Technologies, Inc. to Report First Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on November 17, 2020

PR Newswire

CRANBURY, N.J., Nov. 12, 2020 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter, fiscal year 2021 operating results on Tuesday, November 17, 2020 before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November 17, 2020 at 11:00 a.m. ET. The conference call will include a review of the company’s operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Audio Webcast

Q1 Fiscal Year 2021 Results Press Release                         

11/17/2020 at 7:30 a.m. ET

Q1 Fiscal Year 2021 Conference Call-Live                           

11/17/2020 at 11:00 a.m. ET

US/Canada Dial-In Number:                                                 

1-800-353-6461

International Dial-In Number:                                               

1-334-323-0501

Conference ID:                                                                    

3383273

Q1 Fiscal Year 2021 Conference Call-Replay                   

11/17/2020-11/24/2020

US/Canada Dial-In Number:                                             

1-888-203-1112

International Dial-In Number:                                           

1-719-457-0820

Replay Passcode:                                                           

3383273

Audio Webcast Live and Replay Access                       

http://www.palatin.com

The audio webcast and replay can be accessed by logging on to the “Investors-Webcasts” section of Palatin’s website at http://www.palatin.com.


About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit http://www.palatin.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/palatin-technologies-inc-to-report-first-quarter-fiscal-year-2021-results-teleconference-and-webcast-to-be-held-on-november-17-2020-301171701.html

SOURCE Palatin Technologies, Inc.

IDEXX Laboratories Elects Dr. Asha S. Collins to Board of Directors

PR Newswire

WESTBROOK, Maine, Nov. 12, 2020 /PRNewswire/ — IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today the election of Dr. Asha S. Collins, Head of U.S. Clinical Operations of Genentech, a biotechnology company and member of the Roche Group, to the Company’s Board of Directors, effective November 11, 2020.

“We are pleased to welcome Asha to the IDEXX Board of Directors,” said Larry Kingsley, the Company’s Board Chair. “Asha is a proven entrepreneur, innovator and values-based leader in the healthcare field, and we are confident she will bring a deep scientific understanding, as well as valuable strategic, operational and management experience at life science and healthcare companies, to our Board.”

“I am excited to join the board of a purpose-driven company that leads through innovation to enhance the health and well-being of pets, people and livestock,” said Dr. Collins. “I look forward to working closely with my fellow directors and the IDEXX leadership team to deliver on our purpose while creating long-term value for our stakeholders.”

Dr. Collins has served as the Head of U.S. Clinical Operations at Genentech since May 2018. Prior to joining Genentech, Dr. Collins held several senior leadership positions at McKesson Corporation between September 2014 and March 2018, including Vice President of Clinical Sourcing and Business Development from November 2015 to March 2018 and Senior Director, Corporate Strategy and Business Development from September 2014 to November 2015. She was previously Principal Consultant at Quintiles from 2011 to 2014 and Manager at Deloitte Consulting from 2008 to 2011. In July 2019, Dr. Collins was selected as a Health Innovators Fellow by The Aspen Institute. Dr. Collins received her Bachelor of Science degree from the University of Pittsburgh and her PhD in Cancer Biology and Microbiology from the University of Wisconsin-Madison.

About IDEXX Laboratories
IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency, and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk and point-of-care and laboratory diagnostics for human medicine. Headquartered in Maine, IDEXX employs more than 9,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com.

Note Regarding Forward-Looking Statements

This news release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements can be identified by the use of words such as “expects,” “may,” “anticipates,” “intends,” “would,” “will,” “plans,” “believes,” “estimates,” “should,” “project,” and similar words and expressions. These forward-looking statements are intended to provide our current expectation or forecasts of future events; are based on current estimates, projections, beliefs, and assumptions; and are not guarantees of future performance. Actual events or results may differ materially from those described in the forward-looking statements, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by IDEXX pursuant to United States securities laws contain discussions of some of these risks and uncertainties. IDEXX assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review IDEXX’s filings with the United States Securities and Exchange Commission (which are available from the SEC’s EDGAR database at www.sec.gov and via IDEXX’s website at
www.idexx.com
).


Contact:


Investor Relations



John Ravis


1-207-556-8155

[email protected]
 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/idexx-laboratories-elects-dr-asha-s-collins-to-board-of-directors-301171422.html

SOURCE IDEXX Laboratories, Inc.

Soliton Reports Third Quarter 2020 Results

Conference Call Today at 8:30am ET

PR Newswire

HOUSTON, Nov. 12, 2020 /PRNewswire/ — Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology, today reported financial results for the third quarter ended September 30, 2020.

Third Quarter Company Highlights:

  • Appointed aesthetic veteran Brad Hauser as President and CEO in preparation for commercial product launch
  • Added cosmetic dermatology expert Dr. Michael Kaminer and Niquette Hunt, a medical device and aesthetics industries entrepreneur, to Board of Directors
  • Presented pivotal cellulite data at the Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting
  • Presented pivotal cellulite and tattoo removal data in two separate presentations at the Masters in Aesthetics Symposium
  • Met significant R&D and operations milestones to progress towards launch readiness
  • Enhanced our commercial team with key strategic marketing partners and a new distributor

Brad Hauser, Soliton’s newly appointed President and CEO, commented, “I am truly excited to be joining the Soliton team at such a pivotal time for the Company. During the third quarter, we executed on several key milestones which we believe position us optimally for our planned commercial launch of the RAP device for both tattoo removal and cellulite reduction, pending FDA clearance on the latter. We are extremely proud of our progress with our new, innovative handpiece design and our efforts to successfully transition into manufacturing, recently completing tooling production for the RAP device. Through key partnerships with two excellent marketing agencies and a new distributor, that specializes on high volume tattoo removal practices, we have bolstered our commercial strategy to enhance future customer engagement and receptivity. With these achievements and our current balance sheet, we believe we are well-funded and well-prepared to execute a successful initial launch in the first half of 2021.”

Third Quarter 2020 Financial Results:

Operating expenses for the third quarter ended September 30, 2020 were $3.7 million, as compared to $4.3 million in the third quarter of 2019. The decrease was primarily due to lower research and development expenses as a result of lower expenses for contract engineering and clinical trial costs.

Net loss for the third quarter ended September 30, 2020 was $3.6 million, or ($0.17) basic and diluted net loss per share, compared with net loss of $4.3 million, or ($0.27) basic and diluted net loss per share, for the third quarter of 2019.

Total cash, cash equivalents and restricted cash was $34.8 million as of September 30, 2020, as compared to $12.1 million as of December 31, 2019. The Company’s cash, cash equivalents and restricted cash on hand is expected to be sufficient to fund the Company’s operations into the third quarter of 2022.

Conference Call Details:

Management will host a conference call and live webcast to discuss Soliton’s financial results at 8:30 a.m. ET today. A question and answer session will follow management remarks.

The dial-in numbers for the conference call are (833) 423-0479 for domestic callers and (918) 922-2373 for international callers.  The conference ID is 3493411.

A replay of the call will be available following its completion through November 19, 2020. To access the replay, dial (855) 859-2056 for domestic callers and (404) 537-3406 for international callers and use the replay conference ID 3493411.

A live audio webcast of the call and an updated investor presentation will be available on the Investor Relations page of the Soliton, Inc. website, https://ir.soliton.com/. A replay of the webcast will be archived on Soliton’s website for 30 days following the completion of the call. 

————————

Join our more than 200K subscribers here to follow the Company: https://soly-investors.com

————————

About Soliton, Inc.

Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer Center. The Company’s first FDA cleared commercial product will use rapid pulses of acoustic shockwaves as an accessory to lasers for the removal of unwanted tattoos. The Company is based in Houston, Texas, and is actively engaged in bringing the Rapid Acoustic Pulse (“RAP”) device to the market. The Company believes this “Soliton” method has the potential to lower tattoo removal costs for patients, while increasing profitability to practitioners, compared to current laser removal methods. Soliton has filed a 510(k) application with the FDA for clearance of its RAP device to improve the appearance of cellulite and is investigating potential additional capabilities of the RAP technology. The device is currently cleared in the United States only for use in tattoo removal and is not yet cleared for use to address cellulite.

For more information about the Company, please visit:  http://www.soliton.com

Forward Looking Statements

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the runway for our existing cash to extend into Q3 2022, our ability to launch our RAP device in the first half of 2021, our ability to receive FDA clearance for the cellulite indication and to effectively commercialize our products, and the ability of the RAP device to successfully treat cellulite. These statements relate to future events, future expectations, plans and prospects. Although Soliton believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Soliton has attempted to identify forward-looking statements by terminology including ”believes,” ”estimates,” ”anticipates,” ”expects,” ”plans,” ”projects,” ”intends,” ”potential,” ”may,” ”could,” ”might,” ”will,” ”should,” ”approximately” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under in our SEC filings, including under the heading “Item 1A. Risk Factors” in the Form 10-K for year ended December 31, 2019 we filed with the SEC on March 2, 2020 and updated from time to time in our Form 10-Q filings and in our other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. Soliton undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/soliton-reports-third-quarter-2020-results-301171368.html

SOURCE Soliton, Inc.

R.J. O’Brien Selects Broadridge to Transform its Exchange-Traded Derivatives Operations Globally

PR Newswire

NEW YORK, Nov. 12, 2020 /PRNewswire/ —  Broadridge Financial Solutions, Inc. (NYSE:BR), a global Fintech leader, today announced that R.J. O’Brien & Associates (RJO), the oldest and largest independent futures brokerage and clearing firm in the United States, has selected Broadridge’s post-trade platform to deliver transformational levels of efficiency across its global exchange-traded derivatives operations.

Broadridge’s advanced, integrated processing platform for global derivatives will provide RJO with a scalable, agile platform to support its strategic growth plans and adapt to market change. RJO will gain significant productivity and performance improvements through streamlined, real-time processing workflows and proactive exception management rationalizing processes previously conducted using two major back-office systems in the U.S. and UK.

The new platform will reduce the complexity and cost of running two separate back-office systems, without the need to maintain the technology and hardware. It will provide RJO with a single solution for all asset classes supported by the firm globally.

“We selected Broadridge as our strategic partner on this important infrastructure initiative to help us set a new industry standard for global derivatives processing,” said Gerald Corcoran, RJO Chairman and CEO.  “We share a vision with Broadridge for service excellence, transparency and an agile approach to meeting evolving and emerging business requirements. Many of the world’s largest banks and securities firms leverage Broadridge solutions on the securities side; we are excited to forge new ground as Broadridge’s first customer of this important new back-office platform for exchange-traded derivatives. We were similarly a first mover over three decades ago in adopting a back-office platform that later became the flagship system in the industry.”

“Working with our platform, RJO will be able to capitalize on the latest technology innovations to meet market change requirements and help drive future growth and redefine its business,” said Samir Pandiri, President, Broadridge International. “It is a privilege to work with RJO, a globally recognized derivatives leader, to support and enable its global exchange-traded derivatives transformation strategy.”

About Broadridge

Broadridge Financial Solutions, Inc. (NYSE: BR), a $4 billion global Fintech leader, is a leading provider of investor communications and technology-driven solutions to banks, broker-dealers, asset and wealth managers and corporate issuers. Broadridge’s infrastructure underpins proxy voting services for over 50 percent of public companies and mutual funds globally, and processes on average more than $8 trillion in fixed income and equity securities trades per day. Broadridge is part of the S&P 500® Index and employs over 12,000 associates in 17 countries.

For more information about Broadridge, please visit www.broadridge.com.

About R.J. O’Brien & Associates

Founded in 1914, R.J. O’Brien & Associates is the largest independent futures brokerage and clearing firm in the United States, serving more than 80,000 institutional, commercial and individual clients globally, in addition to a network of approximately 300 introducing brokers (IBs). RJO services the industry’s most expansive global network of IBs, a vast array of middle market firms and many of the world’s largest financial, industrial and agricultural institutions. The firm offers state-of-the-art electronic trading and 24-hour trade execution on every major futures exchange worldwide. RJO has received the FOW International Award for Non-Bank FCM of the Year for the past four years. Wealth and Finance International Magazine named the company’s private client division, RJO Futures, 2018’s Most Trusted Financial Brokerage Firm. At the HFM US Quant Awards 2020, RJO won the award for Best Independent FCM – the eighth honor bestowed by the HFM Global publications on RJO and its UK affiliate.

Contact Information

Investors:
W. Edings Thibault
Investor Relations
(516) 472-5129

Media:
For Broadridge:
Gregg Rosenberg 
Corporate Communications, Broadridge
(212) 918-6966
[email protected]

For R.J. O’Brien:
Ellen G. Resnick
Crystal Clear Communications
+773-929-9292; +312-399-9295 (mobile)
[email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/rj-obrien-selects-broadridge-to-transform-its-exchange-traded-derivatives-operations-globally-301171702.html

SOURCE Broadridge Financial Solutions, Inc.; R.J. O’Brien & Associates

Maple Leaf Foods Ranked Second Globally in 2020 Coller FAIRR Protein Producer Index of Environmental, Social and Governance Performance

PR Newswire

One year after achieving carbon neutrality, Maple Leaf Foods ranked second globally in the Coller FAIRR Protein Producer Index, the world’s only comprehensive sustainability ranking of the 60 largest publicly traded animal protein producers

MISSISSAUGA, ON, Nov. 12, 2020 /PRNewswire/ – Maple Leaf Foods Inc. (TSX: MFI), a leading North American producer of high-quality, sustainable meat and plant-based proteins, announced today that it has been ranked second and one of only three ‘low risk’ investments globally in the 2020 Coller FAIRR Protein Producer Index, marking another key step in the organization’s purposeful journey to become the most sustainable protein company on earth.

The Coller FAIRR Protein Producer Index* is an award-winning environmental, social, and governance (ESG) ranking of the world’s 60 largest publicly traded protein producers. Companies are assigned scores against ten sustainability factors including: governance, greenhouse gas emissions; deforestation and biodiversity loss; water scarcity and use; waste and pollution; antibiotics; animal welfare; working conditions, food safety, and alternative proteins.

“We are grateful that the meaningful progress we made on our sustainability journey throughout 2020 has been recognized by the Coller FAIRR Protein Producer Index,” said Michael McCain, President and CEO. “At Maple Leaf Foods, we believe that real change results from meaningful action.  We are acting with urgency to address the negative impact of carbon emissions and to create better food, better care, better communities and a better planet now and for future generations.”   

In 2019, Maple Leaf Foods was ranked 7th globally in the Coller FAIRR Index, and in the past year, since achieving carbon neutrality and becoming one of only three animal protein companies in the world to adopt science-based emissions targets, the company has risen in the ranking to second. Not only is Maple Leaf Foods one of the highest ranked companies globally, it is the only Canadian protein producer included on the ranking and is the highest ranked protein producer in North America.

“Sustainability is integral to everything we do and make at Maple Leaf Foods,” said McCain. “We are proud to see our dedication to a healthy planet and a healthy future for all people reflected in our global ranking as one of the most sustainable protein companies on earth – and to demonstrate that sustainability and a thriving business are not mutually exclusive goals. Maple Leaf Foods intends to lead in sustainability for years to come, and we have ambitious science-based targets that will propel us toward our goal of becoming the most sustainable protein company on earth.”

Maple Leaf Foods’ leadership in plant protein was one of the key factors that contributed to the company’s rise in the global rankings. In fact, Maple Leaf Foods is the only company to achieve a 100% score in the alternative protein category in the 2020 Coller FAIRR Index, and the only company to have set a target to achieve $3 billion in plant protein sales by 2029.* In 2020, Maple Leaf Foods enhanced its leadership in alternative proteins by introducing the new fusion protein category with the launch of Maple Leaf 50/50™. A direct response to rising consumer interest in flexitarian eating and plant-based protein, Maple Leaf 50/50™ products are made with 50% premium quality meat and 50% natural and plant-based protein for consumers who want to make sustainable protein choices for themselves, their family and the planet – without giving up meat entirely.

Sustainability is a company-wide initiative at Maple Leaf Foods that encompasses every aspect of the business. Next steps on the company’s journey to become the most sustainable protein company on earth include achieving a 50% intensity reduction in its environmental footprint and food waste by 2025, and reducing absolute Scope 1 & 2 greenhouse gas emissions and Scope 3 emissions per tonne of product produced by 30%, by 2030 following science-based targets. Maple Leaf Foods is also committed to maintaining its net carbon footprint at zero, through focusing on avoiding and reducing emissions and offsetting unavoidable emissions that currently cannot be reduced. The company has invested in 11 high-impact environmental projects across North America, including waste diversion renewable energy and forestry initiatives.

To learn more about sustainability at Maple Leaf Foods, visit: mapleleaffoods.com/sustainability

To learn more about Maple Leaf Foods brands, visit: mapleleaffoods.com/our-brands

To learn more about Maple Leaf Foods’ investment in high impact environmental projects, visit:

https://mapleleaf.worksclient.ca/wp-content/uploads/2019/11/Maple-Leaf-Foods-Carbon-Projects-Fact-Sheet.pdf


About Maple Leaf Foods

Maple Leaf Foods is a producer of food products under leading brands including Maple Leaf®, Maple Leaf Prime®, Maple Leaf Natural Selections®, Schneider’s®, Schneiders®, Country Naturals®, Mina®, Greenfield Natural Meat Co.®, Lightlife®, Field Roast Grain Meat Co.™ and Swift®. Maple Leaf employs approximately 13,000 people and does business in Canada, the U.S. and Asia. The Company is headquartered in Mississauga, Ontario and its shares trade on the Toronto Stock Exchange (MFI).


Forward-Looking Statements

This news release contains forward-looking statements based on the Company’s current expectations and assumptions relating to its environmental performance, its sustainability and emission reduction efforts, as well as the effectiveness of these efforts and initiatives. As these forward-looking statements depend upon future events, actual outcomes may differ materially depending on factors such as: operating performance, the results of sustainability and emission reduction initiatives, the performance of third parties from whom off-sets are purchased and the third-party certification processes for off-sets. These statements are based on current expectations, estimates, forecasts, and projections but there can be no assurance that the results or developments anticipated by the Company will be realized. For more information refer to the Company’s Annual Management’s Discussion and Analysis for the year ended December 31, 2019, its most Annual Information Form (both available on SEDAR at www.sedar.com) and its most recent Sustainability Report available at www.mapleleaffoods.com.

*Coller FAIRR Protein Producer Index, November 11, 2020 [https://www.businesswire.com/news/home/20201111005107/en/Food-Giant-Pledges-Undermined-by-%E2%80%9CPlodding%E2%80%9D-Meat-and-Dairy-Industry-On-COVID-and-Climate]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/maple-leaf-foods-ranked-second-globally-in-2020-coller-fairr-protein-producer-index-of-environmental-social-and-governance-performance-301171389.html

SOURCE Maple Leaf Foods Inc.

Aehr Test Systems to Participate at Craig-Hallum Alpha Select Virtual Conference on November 17, 2020

FREEMONT, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced that it will participate at the Craig-Hallum 11th Annual Alpha Select Virtual Conference on Tuesday, November 17, 2020. Aehr Test President and CEO Gayn Erickson and CFO Ken Spink will be hosting virtual meetings with investors throughout the day.

“We look forward to discussing our semiconductor wafer level and singulated die test and burn-in solutions and the markets they serve with investors,” said Mr. Erickson. “Aehr Test provides complete production solutions for improving yield and reliability of semiconductors, and devices such as silicon carbide semiconductors used in electric and hybrid electric vehicles, silicon photonics devices used in data centers and 5G infrastructure, and 2D/3D and other sensors used in mobile and wearable applications, which are expected to be significant revenue drivers for our products this fiscal year and next.”

For additional information, or to schedule a virtual meeting with Aehr management, please contact your Craig-Hallum representative, or Aehr’s investor relations firm, MKR Investor Relations, at [email protected].

About Aehr Test Systems

Headquartered in Fremont, California, Aehr Test Systems is a worldwide provider of test systems for burning-in and testing logic, optical and memory integrated circuits and has installed over 2,500 systems worldwide. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products in package, wafer level, and singulated die/module level test. Aehr Test has developed and introduced several innovative products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The ABTS system is used in production and qualification testing of packaged parts for both lower power and higher power logic devices as well as all common types of memory devices. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems used for burn-in and functional test of complex devices, such as leading-edge memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices. The FOX-CP system is a new low-cost single-wafer compact test and reliability verification solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The WaferPak contactor contains a unique full wafer probe card capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems. The DiePak Carrier is a reusable, temporary package that enables IC manufacturers to perform cost-effective final test and burn-in of both bare die and modules. For more information, please visit Aehr Test Systems’ website at www.aehr.com.

Contacts:  
   
Aehr Test Systems MKR Investor Relations Inc.
Ken Spink Todd Kehrli or Jim Byers
Chief Financial Officer Analyst/Investor Contact
(510) 623-9400 x309 (323) 468-2300
  [email protected]

LiquidityBook Launches Standalone CAT Reporting Solution

Early clients, including industry-leading outsourced trading solutions provider Tourmaline Partners, see immediate cost, performance and functionality benefits

New York, Nov. 12, 2020 (GLOBE NEWSWIRE) — LiquidityBook, a leading Software-as-a-Service (SaaS)-based provider of buy- and sell-side trading solutions, today announced the launch of a new Consolidated Audit Trail (CAT) reporting solution. CAT reporting has always been among the sell-side reporting functionalities available to LiquidityBook’s OMS customers, but demand from non-OMS clients prompted the firm to develop a solution on a standalone basis for those who using either a competing OMS or no OMS at all.

The new functionality will help broker-dealers – including Outsourced Trading firms using LiquidityBook’s LBX Outsourced Trader platform – navigate the transition from Order Audit Trail System (OATS) reporting to CAT reporting. The phased rollout of the new reporting regime began earlier this year, and Phase 2a – in which large industry members and small OATS reporters alike must begin reporting firm-to-firm linkage validations and equity exchange and TRF linkage validations – began on October 26.

The solution, which was soft launched to a select group of high-performance clients earlier this year, will be particularly impactful for firms that do not use an OMS and whose EMS providers do not support CAT reporting. Already, LiquidityBook has onboarded several clients whose previous systems could no longer support the reporting requirements of the new regulatory order.

“Given that the CAT has had an enormous effect on how trading firms handle their customer data, we saw a large amount of interest from firms whose existing OMS and/or EMS provider could not provide the reporting capability for one reason or another, leaving firms with a very clear business risk to their organization – perhaps rendering it inoperable,” said Sean Sullivan, Chief Revenue Officer at LiquidityBook. “Our team has built a solution that will help the industry navigate this shifting regulatory landscape. We are pleased to be able to fill the void and offer CAT reporting to players who were underserved by their previous systems as well as our existing clients.”

“There is no question that the implementation of CAT has created new complexities from a compliance standpoint,” said Daniel Dispigna, Chief Operating Officer at Tourmaline Partners, an industry-leading outsourced trading solutions provider and longtime LiquidityBook client. “Working with LiquidityBook allows us to meet these challenges with as much efficiency as possible. Their reporting solution is robust and versatile, helping us satisfy our own reporting requirements as well as serve the needs of our diverse and growing client base.”

The new CAT reporting tool is the latest addition to LiquidityBook’s suite of regulatory reporting solutions. The firm has offered MiFID II reporting tools since the framework’s implementation in early 2018, and more recently it upgraded its SEC Rules 605 and 606 reporting toolkit to meet the new requirements introduced earlier this year.

About LiquidityBook

LiquidityBook is a leading SaaS-based provider of buy- and sell-side trading solutions, including order management, portfolio management, execution management, FIX network connectivity, compliance and pre- and post-trade processing. Founded in 2005, the LiquidityBook platform is trusted by many of the industry’s most sophisticated buy- and sell-side firms globally to power their trading workflows. For more information please visit www.liquiditybook.com or contact [email protected].

Sam Belden
Forefront Communications for LiquidityBook
212-320-8986
[email protected]

Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) — Cytovia Therapeutics, an emerging biopharmaceutical company developing Natural Killer Cell Therapeutics, today announced that it will participate in the Jefferies Virtual London Healthcare Conference which will take place from November 17 to 19th, 2020. 

  • Cytovia CEO Dr. Daniel Teper will present on Thursday, November 19th at 12.55 PM GMT – 7.55 AM EST.
  • Company management will be available throughout the conference for one on one virtual meetings from November 17 to November 19, 2020.
  • The webcast links will be available on the company website and social media pages. 

ABOUT CYTOVIA THERAPEUTICS

Cytovia Therapeutics Inc is an emerging biotechnology company that aims to accelerate patient access to transformational immunotherapies, addressing several of the most challenging unmet medical needs in cancer. Cytovia focuses on Natural Killer (NK) cell biology and is leveraging multiple advanced patented technologies, including an induced pluripotent stem cell (iPSC) platform for CAR (Chimeric Antigen Receptors) NK cell therapy, next-generation precision gene-editing to enhance targeting of NK cells, and NK engager multi-functional antibodies. Our initial product portfolio focuses on both hematological malignancies such as multiple myeloma and solid tumors including hepatocellular carcinoma and glioblastoma. The company partners with the University of California San Francisco (UCSF), the New York Stem Cell Foundation (NYSCF), the Hebrew University of Jerusalem, INSERM and CytoImmune Therapeutics.

Learn more at www.cytoviatx.com and follow Cytovia Therapeutics on Social Media FacebookLinkedInTwitter.

For more information please contact:

Cytovia Therapeutics, Inc
Sophie Badré, Vice President, Corporate Affairs
[email protected] 
Cell: 1 (929) 317 1565 

Anna Baran
-Djokovic, VP Investor Relations
[email protected]
VP Investor Relations
Cell: +44 7521083006